par Bachet, Jean-Baptiste;Marechal, Raphaël ;Demetter, Pieter ;Bonnetain, F;Couvelard, Anne;Svrcek, Magali;Bardier-Dupas, Armelle;Hammel, P;Sauvanet, Alain;Louvet, C;Paye, François;Rougier, Philippe;Penna, C;Vaillant, J C;André, T;Closset, Jean ;Salmon, Isabelle ;Emile, Jean-François;Van Laethem, Jean-Luc
Référence Annals of oncology, 23, 9, page (2327-2335)
Publication Publié, 2012-09
Référence Annals of oncology, 23, 9, page (2327-2335)
Publication Publié, 2012-09
Article révisé par les pairs
Résumé : | Prognosis of patients with pancreatic adenocarcinoma is poor. Many prognostic biomarkers have been tested, but most studies included heterogeneous patients. We aimed to investigate the prognostic and/or predictive values of four relevant biomarkers in a multicentric cohort of patients. |